Brucellosis is a worldwide distributed zoonosis that causes important economic losses to animal production. In Brazil, information on the distribution of biovars and genotypes of Brucella spp. is scarce or unavailable. This study aimed (i) to biotype and genotype 137 Brazilian cattle isolates (from 1977 to 2008) of B. abortus and (ii) to analyze their distribution. B. abortus biovars 1, 2 and 3 (subgroup 3b) were confirmed and biovars 4 and 6 were first described in Brazil. Genotyping by the panel 1 revealed two groups, one clustering around genotype 40 and another around genotype 28. Panels 2A and 2B disclosed a high diversity among Brazilian B. abortus strains. Eighty-nine genotypes were found by MLVA16. MLVA16 panel 1 and 2 showed geographic clustering of some genotypes. Biotyping and MLVA16 genotyping of Brazilian B. abortus isolates were useful to better understand the epidemiology of bovine brucellosis in the region.
The NRAMP1 gene encodes a divalent cation transporter, located in the phagolysosomal membrane of macrophages, that has been associated with resistance to intracellular pathogens. In cattle, natural resistance against brucellosis has been associated with polymorphisms at the 3 untranslated region (3UTR) of the NRAMP1 gene, which are detectable by single-strand conformational analysis (SSCA). This study aimed to evaluate the association between NRAMP1 3UTR polymorphisms and resistance against bovine brucellosis in experimental and natural infections. In experimentally infected pregnant cows, abortion occurred in 42.1% of cows with a resistant genotype (SSCA r ; n ؍ 19) and in 43.1% of those with a susceptible genotype (SSCA s ; n ؍ 23). Furthermore, no association between intensity of pathological changes and genotype was detected. In a farm with a very high prevalence of bovine brucellosis, the percentages of strains of the SSCA r genotype were 86 and 84% in serologically positive (n ؍ 64) and negative (n ؍ 36) cows, respectively. Therefore, no association was found between the NRAMP1-resistant allele and the resistant phenotype in either experimental or naturally occurring brucellosis. To further support these results, bacterial intracellular survival was assessed in bovine monocyte-derived macrophages from cattle with either the resistant or susceptible genotype. In agreement with our previous results, no difference was observed in the rates of intracellular survival of B. abortus within macrophages from cattle with susceptible or resistant genotypes. Taken together, these results indicate that these polymorphisms at the NRAMP1 3UTR do not affect resistance against B. abortus in cattle and that they are therefore not suitable markers of natural resistance against bovine brucellosis.
Brucellosis is an important zoonosis and a significant cause of reproductive losses in animals. Abortion, placentitis, epididymitis, and orchitis are the most common clinical manifestations in animals. In humans, brucellosis is a debilitating and chronic disease, which may affect a variety of organs. Clinical diagnosis of brucellosis is not easily achieved. Laboratory testing is therefore very important for a correct identification of the disease in humans and for the detection and confirmation in animals. Definitive diagnosis is normally done by isolation and identification of the causative agent. While definitive, isolation is time-consuming, must be performed by highly skilled personnel, and it is hazardous. For these reasons, serological tests are normally preferred. Brucellosis serology have advanced considerably in the last decades with very sensitive and specific new tests available. Modern genetic characterization of Brucellae using molecular DNA technology have been developed. Several PCR-based assays have been proposed, from the rapid recognition of genus to differential identification of species and strains. This review describes bacteriological, serological, and molecular methods used for the diagnosis of human and animal brucellosis.
RESUMOAs estratégias de combate à brucelose bovina são bastante conhecidas e, até o momento, os resultados são divergentes. No Brasil, o Ministério da Agricultura, Pecuária e Abastecimento (MAPA) implementou, em 2001, o Programa Nacional de Controle e Erradicação da Brucelose e Tuberculose. Conhecer a situação epidemiológica da brucelose no início de um programa de controle permite: 1 -escolher as melhores estratégias de controle em função da frequência e padrão de distribuição da doença na população e 2 -acompanhar o programa com a finalidade de promover correções e evitar o desperdício de tempo e de recursos. Em razão disso, é necessário realizar estudos para dar suporte à escolha das melhores estratégias para os vários estados e regiões brasileiras e criar um mecanismo racional de verificação da efetividade das ações implementadas. Para tanto, o MAPA estabeleceu um Termo de Cooperação Técnica com a Faculdade de Medicina Veterinária da Universidade de São Paulo e envolveu também a Faculdade de Agronomia e Veterinária da Universidade de Brasília. Até o momento, foram concluídos os estudos de 15 unidades federativas, cujos resultados são apresentados nos artigos subsequentes. Além disso, há um 16º artigo que explora o impacto da vacinação de bezerras com a B19 na redução da prevalência da brucelose.Palavras-chave: brucelose bovina, programa de erradicação, Brasil
ABSTRACT
Although strategies for controlling and eradicating of bovine brucellosis are well known, the achievements vary widely. In 2001, the Brazilian Ministry of Agriculture, Livestock, and Food Supply (MAPA) started a new National Program for the Control and Eradication of Brucellosis and Tuberculosis (NPCEBT). In the beginning of a brucellosis control program, it is of utmost importance to gain insights into the epidemiological status of the disease in order to
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.